These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Isolation of recombinant tetrameric N-acetylated α-synuclein. Fernández RD; Lucas HR Protein Expr Purif; 2018 Dec; 152():146-154. PubMed ID: 30041032 [TBL] [Abstract][Full Text] [Related]
7. α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation. Bartels T; Choi JG; Selkoe DJ Nature; 2011 Aug; 477(7362):107-10. PubMed ID: 21841800 [TBL] [Abstract][Full Text] [Related]
8. Distinct phases of free α-synuclein--a Monte Carlo study. Jónsson SA; Mohanty S; Irbäck A Proteins; 2012 Aug; 80(9):2169-77. PubMed ID: 22552968 [TBL] [Abstract][Full Text] [Related]
9. Potential of mean force and molecular dynamics study on the transient interactions between α and β synuclein that drive inhibition of α-synuclein aggregation. Sanjeev A; Sahu RK; Mattaparthi VSK J Biomol Struct Dyn; 2017 Nov; 35(15):3342-3353. PubMed ID: 27809690 [TBL] [Abstract][Full Text] [Related]
10. Dimerization of Tyr136Cys alpha-synuclein prevents amyloid transformation of wild type alpha-synuclein. Barinova KV; Kuravsky ML; Arutyunyan AM; Serebryakova MV; Schmalhausen EV; Muronetz VI Int J Biol Macromol; 2017 Mar; 96():35-43. PubMed ID: 27939273 [TBL] [Abstract][Full Text] [Related]
12. Alpha-synuclein and familial variants affect the chain order and the thermotropic phase behavior of anionic lipid vesicles. Pantusa M; Vad B; Lillelund O; Kjær L; Otzen D; Bartucci R Biochim Biophys Acta; 2016 Sep; 1864(9):1206-1214. PubMed ID: 27177693 [TBL] [Abstract][Full Text] [Related]
13. Molecular Simulations Reveal Terminal Group Mediated Stabilization of Helical Conformers in Both Amyloid-β42 and α-Synuclein. Bhattacharya S; Xu L; Thompson D ACS Chem Neurosci; 2019 Jun; 10(6):2830-2842. PubMed ID: 30917651 [TBL] [Abstract][Full Text] [Related]
14. Computational Study on the Role of γ-Synuclein in Inhibiting the α-Synuclein Aggregation. Sanjeev A; Mattaparthi VSK Cent Nerv Syst Agents Med Chem; 2019; 19(1):24-30. PubMed ID: 30318002 [TBL] [Abstract][Full Text] [Related]
15. Computational investigation on the effects of H50Q and G51D mutations on the α-Synuclein aggregation propensity. Sanjeev A; Mattaparthi VSK J Biomol Struct Dyn; 2018 Jul; 36(9):2224-2236. PubMed ID: 28650719 [TBL] [Abstract][Full Text] [Related]
16. Membrane-bound structure and energetics of alpha-synuclein. Mihajlovic M; Lazaridis T Proteins; 2008 Feb; 70(3):761-78. PubMed ID: 17729279 [TBL] [Abstract][Full Text] [Related]
17. Curvature dynamics of alpha-synuclein familial Parkinson disease mutants: molecular simulations of the micelle- and bilayer-bound forms. Perlmutter JD; Braun AR; Sachs JN J Biol Chem; 2009 Mar; 284(11):7177-89. PubMed ID: 19126542 [TBL] [Abstract][Full Text] [Related]
18. α-Synuclein oligomers with broken helical conformation form lipoprotein nanoparticles. Varkey J; Mizuno N; Hegde BG; Cheng N; Steven AC; Langen R J Biol Chem; 2013 Jun; 288(24):17620-30. PubMed ID: 23609437 [TBL] [Abstract][Full Text] [Related]